G
Gordon H. Guyatt
Researcher at McMaster University
Publications - 1749
Citations - 262329
Gordon H. Guyatt is an academic researcher from McMaster University. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 231, co-authored 1620 publications receiving 228631 citations. Previous affiliations of Gordon H. Guyatt include Memorial Sloan Kettering Cancer Center & Cayetano Heredia University.
Papers
More filters
Journal ArticleDOI
Users' guides to the Medical Literature. VIII. How to use clinical practice guidelines. B. what are the recommendations and will they help you in caring for your patients? The Evidence-Based Medicine Working Group.
Journal ArticleDOI
Users' guides to the medical literature XVI. How to use a treatment recommendation
TL;DR: This work proposes a hierarchy of rigor of recommendations to guide clinicians when judging the usefulness of particular recommendations, and in an era in which clinicians are barraged by recommendations as to how to manage their patients, this hierarchy provides a potentially useful set of guides.
Journal ArticleDOI
Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability.
Kristian Thorlund,Stephen D. Walter,Bradley C. Johnston,Bradley C. Johnston,Toshi A. Furukawa,Gordon H. Guyatt +5 more
TL;DR: 12 approaches in three categories are identified for enhancing interpretability and usefulness of systematic reviews involving HRQL outcomes: summary estimates derived from the pooled standardized mean difference, conversion to units of the most familiar instrument or to risk difference or odds ratio.
Journal ArticleDOI
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
Ling Li,Sheyu Li,Ke Deng,Jiali Liu,Per Olav Vandvik,Pujing Zhao,Longhao Zhang,Jiantong Shen,Malgorzata M Bala,Zahra N. Sohani,Evelyn Wong,Jason W. Busse,Shanil Ebrahim,Germán Málaga,Lorena P. Rios,Yingqiang Wang,Qunfei Chen,Gordon H. Guyatt,Xin Sun +18 more
TL;DR: Both randomised controlled trials and observational studies suggest that DPP-4 inhibitors may increase the risk of hospital admission for heart failure in those patients with existing cardiovascular diseases or multiple risk factors for vascular diseases, compared with no use.
Journal ArticleDOI
Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.
Elizabeth F. Juniper,Patrick Johnston,Cornelia M. Borkhoff,Gordon H. Guyatt,Louis-Philippe Boulet,A Haukioja +5 more
TL;DR: Asthma-specific quality of life, both overall and for the individual domains (activity limitation, symptoms, emotional function, and exposure to environmental stimuli) was better with Salmeterol than with placebo, and better with salmeterol more than with salbutamol (p < 0.001).